Show simple item record

dc.contributor.authorQuarmby, Steven Len
dc.contributor.authorHunter, Robin Den
dc.contributor.authorKumar, Shanten
dc.date.accessioned2009-11-23T10:00:11Z
dc.date.available2009-11-23T10:00:11Z
dc.date.issued2000
dc.identifier.citationIrradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells., 20 (5B):3375-81 Anticancer Res.en
dc.identifier.issn0250-7005
dc.identifier.pmid11131637
dc.identifier.urihttp://hdl.handle.net/10541/86658
dc.description.abstractThe adherence and migration of leukocytes through the endothelium of blood vessels is an important early event which occurs in normal tissues following ionizing irradiation but the underlying mechanisms are not fully understood. ICAM-1, VCAM-1 and CD31 are membrane proteins of endothelial cells, mediate this process when the vasculature is exposed to other inflammatory stimuli. In this study, expression of ICAM-1, VCAM-1 and CD31 on human dermal microvascular endothelial cells (HDMECs) at 72 hours post-irradiation using flow cytometry and northern analysis was determined. Dose-dependent increases in the surface expression and mRNA of ICAM-1 and CD31 were observed. In contrast VCAM-1 was practically undetectable on both control and irradiated HDMECs but was strongly expressed in TNF-alpha activated positive control HDMECs. The upregulation in ICAM-1 and CD31 was independent of radiation-induced changes in cell size, number and cell cycle stage. We suggest that ICAM-1 is active over a prolonged period whereas VCAM-1 acts only transiently in leukocyte-endothelial interactions in the irradiated microvasculature. The late upregulation of CD31 is a novel finding and may have a function in radiation-induced leukocyte extravasation, platelet adherence to the vascular wall and abnormal endothelial cell proliferation. Both ICAM-1 and CD31 seem to be therapeutic targets for the amelioration of radiation-induced normal tissue damage.
dc.language.isoenen
dc.subject.meshAntigens, CD31
dc.subject.meshBlotting, Northern
dc.subject.meshCell Adhesion Molecules
dc.subject.meshCell Culture Techniques
dc.subject.meshCell Cycle
dc.subject.meshCell Membrane
dc.subject.meshCell Size
dc.subject.meshDose-Response Relationship, Radiation
dc.subject.meshEndothelium, Vascular
dc.subject.meshFlow Cytometry
dc.subject.meshGene Expression Regulation
dc.subject.meshHumans
dc.subject.meshIntercellular Adhesion Molecule-1
dc.subject.meshRNA, Messenger
dc.subject.meshSkin
dc.subject.meshUp-Regulation
dc.subject.meshVascular Cell Adhesion Molecule-1
dc.titleIrradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells.en
dc.typeArticleen
dc.contributor.departmentDepartment of Pathological Sciences, Medical School, Manchester University M13 9PT, U.K. steven.l.quarmby@man.ac.uken
dc.identifier.journalAnticancer Researchen
html.description.abstractThe adherence and migration of leukocytes through the endothelium of blood vessels is an important early event which occurs in normal tissues following ionizing irradiation but the underlying mechanisms are not fully understood. ICAM-1, VCAM-1 and CD31 are membrane proteins of endothelial cells, mediate this process when the vasculature is exposed to other inflammatory stimuli. In this study, expression of ICAM-1, VCAM-1 and CD31 on human dermal microvascular endothelial cells (HDMECs) at 72 hours post-irradiation using flow cytometry and northern analysis was determined. Dose-dependent increases in the surface expression and mRNA of ICAM-1 and CD31 were observed. In contrast VCAM-1 was practically undetectable on both control and irradiated HDMECs but was strongly expressed in TNF-alpha activated positive control HDMECs. The upregulation in ICAM-1 and CD31 was independent of radiation-induced changes in cell size, number and cell cycle stage. We suggest that ICAM-1 is active over a prolonged period whereas VCAM-1 acts only transiently in leukocyte-endothelial interactions in the irradiated microvasculature. The late upregulation of CD31 is a novel finding and may have a function in radiation-induced leukocyte extravasation, platelet adherence to the vascular wall and abnormal endothelial cell proliferation. Both ICAM-1 and CD31 seem to be therapeutic targets for the amelioration of radiation-induced normal tissue damage.


This item appears in the following Collection(s)

Show simple item record